Skip to content

Clinical trials

Completed Phase 1/2 Lymphoma, B-Cell, Marginal Zone trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell, Marginal Zone Phase: Phase 1/2 Status: Completed Clear all

53 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20011
20021
20033
20042
20055
20061
20072
20082
20094
20101
20114
20122
20143
20161
20173
20182
20191
20202

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed53

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center5
Mayo Clinic5
National Cancer Institute (NCI)3
BeiGene2
Garden State Cancer Center at the Center for Molecular Medicine and Immunology2
Gilead Sciences2
Memorial Sloan Kettering Cancer Center2
Northwestern University2
Robert Lowsky2
UNC Lineberger Comprehensive Cancer Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell, Marginal Zone53
Lymphoma, Follicular51
Lymphoma, Mantle-Cell46
Leukemia, Lymphocytic, Chronic, B-Cell44
Lymphoma, Non-Hodgkin37
Lymphoma, Large B-Cell, Diffuse36
Lymphoma28
Burkitt Lymphoma26
Waldenstrom Macroglobulinemia25
Hodgkin Disease24

Trials

Showing 1 to 25 of 53. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.